1. Home
  2. SXTP vs SHPH Comparison

SXTP vs SHPH Comparison

Compare SXTP & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 60 Degrees Pharmaceuticals Inc.

SXTP

60 Degrees Pharmaceuticals Inc.

N/A

Current Price

$1.89

Market Cap

2.9M

Sector

Health Care

ML Signal

N/A

Logo Shuttle Pharmaceuticals Holdings Inc.

SHPH

Shuttle Pharmaceuticals Holdings Inc.

N/A

Current Price

$0.89

Market Cap

4.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SXTP
SHPH
Founded
2010
2012
Country
United States
United States
Employees
3
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9M
4.2M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
SXTP
SHPH
Price
$1.89
$0.89
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$17.60
N/A
AVG Volume (30 Days)
39.9K
79.8K
Earning Date
01-01-0001
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$146.28
N/A
Revenue Next Year
$24.61
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$0.12
52 Week High
$8.62
$5.59

Technical Indicators

Market Signals
Indicator
SXTP
SHPH
Relative Strength Index (RSI) 33.12 35.55
Support Level $1.26 $0.14
Resistance Level $2.58 $2.00
Average True Range (ATR) 0.22 0.10
MACD -0.19 0.01
Stochastic Oscillator 2.04 24.87

Price Performance

Historical Comparison
SXTP
SHPH

About SXTP 60 Degrees Pharmaceuticals Inc.

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.

About SHPH Shuttle Pharmaceuticals Holdings Inc.

Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.

Share on Social Networks: